Resultats de la cerca - McMeekin, D Scott

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents per Moxley, Katherine M., McMeekin, D. Scott

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P per Dizon, Don S., Blessing, John A., McMeekin, D. Scott, Sharma, Sudarshan K., DiSilvestro, Paul, Alvarez, Ronald D.

Obtenir text complet Obtenir text complet Obtenir text complet

A PHASE II TRIAL OF THALIDOMIDE IN PATIENTS WITH REFRACTORY ENDOMETRIAL CANCER AND CORRELATION WITH ANGIOGENESIS BIOMARKERS: A GYNECOLOGIC ONCOLOGY GROUP STUDY per McMeekin, D. Scott, Sill, Michael W., Benbrook, Doris, Darcy, Kathleen M., Stearns-Kurosawa, Deborah J., Eaton, Lynne, Yamada, S. Diane

Obtenir text complet Obtenir text complet Obtenir text complet

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel) in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal... per Coleman, Robert L., Brady, William E., McMeekin, D. Scott, Rose, Peter G., Soper, John T., Lentz, Samuel S., Hoffman, James S., Shahin, Mark S.

Obtenir text complet Obtenir text complet Obtenir text complet

Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion per Lee, Taek Sang, Kim, Jae Weon, Kim, Dae Yeon, Kim, Young Tae, Lee, Ki Heon, Kim, Byoung Gie, McMeekin, D. Scott

Obtenir text complet Obtenir text complet Obtenir text complet

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study per Monk, Bradley J., Sill, Michael W., McMeekin, D. Scott, Cohn, David E., Ramondetta, Lois M., Boardman, Cecelia H., Benda, Jo, Cella, David

Obtenir text complet Obtenir text complet Obtenir text complet

A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy with Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: a Gynecologic Oncology Group Stud... per Rose, Peter G., Sill, Michael W., McMeekin, D. Scott, Ahmed, Amina, Salani, Ritu, Yamada, S. Diane, Wolfson, Aaron, Fusco, Nancy, Fracasso, Paula M.

Obtenir text complet Obtenir text complet Obtenir text complet

A phase II evaluation of Irofulven (IND#55804, NSC#683863) as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cance... per Schilder, Russell J., Blessing, John A., Shahin, Mark S., Miller, David S, Tewari, Krishnansu Sujata, Muller, Carolyn Y., Warshal, David, McMeekin, D. Scott, Rotmensch, Jacob

Obtenir text complet Obtenir text complet

Phase II trial of Cetuximab in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study per Santin, Alessandro D., Sill, Michael W., McMeekin, D. Scott, Leitao, Mario M., Brown, Jubilee, Sutton, Gregory P., Van Le, Linda, Griffin, Patricia, Boardman, Cecelia H.

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study per Aghajanian, Carol, Sill, Michael W., Darcy, Kathleen M., Greer, Benjamin, McMeekin, D. Scott, Rose, Peter G., Rotmensch, Jacob, Barnes, Mack N., Hanjani, Parviz, Leslie, Kimberly K.

Obtenir text complet Obtenir text complet Obtenir text complet

Ultra-early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer per Mayr, Nina A., Yuh, William T. C., Jajoura, David, Wang, Jian Z., Lo, Simon S., Montebello, Joseph F., Porter, Kyle, Zhang, Dongqing, McMeekin, D. Scott, Buatti, John M.

Obtenir text complet Obtenir text complet Obtenir text complet

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass per Moore, Richard G., McMeekin, D. Scott, Brown, Amy K., DiSilvestro, Paul, Miller, M. Craig, Allard, W. Jeffrey, Gajewski, Walter, Kurman, Robert, Bast, Robert C., Skates, Steven J.

Obtenir text complet Obtenir text complet Obtenir text complet

Etiologic Heterogeneity in Endometrial Cancer: Evidence from a Gynecologic Oncology Group Trial per Brinton, Louise A., Felix, Ashley S., McMeekin, D. Scott, Creasman, William T., Sherman, Mark E., Mutch, David, Cohn, David E., Walker, Joan L., Moore, Richard G., Downs, Levi S., Soslow, Robert A., Zaino, Richard

Obtenir text complet Obtenir text complet Obtenir text complet

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial per Felix, Ashley S., Brinton, Louise A., McMeekin, D. Scott, Creasman, William T., Mutch, David, Cohn, David E., Walker, Joan L., Moore, Richard G., Downs, Levi S., Soslow, Robert A., Zaino, Richard, Sherman, Mark E.

Obtenir text complet Obtenir text complet Obtenir text complet

A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer per Moore, Kathleen N., Gunderson, Camille, Sabbatini, Paul, McMeekin, D. Scott, Mantia-Smaldone, Gina, Burger, Robert, Morgan, Mark A., Kapoun, Ann M., Brachmann, Rainer Karl, Stagg, Robert, Farooki, Azeez, O’Cearbhaill, Roisin E

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II Trial of Trastuzumab in Women with Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: a Gynecologic Oncology Group Study per Fleming, Gini F., Sill, Michael W., Darcy, Kathleen M., McMeekin, D. Scott, Thigpen, J. Tate, Adler, Lisa M., Berek, Jonathan S., Chapman, Julia A., DiSilvestro, Paul A., Horowitz, Ira R., Fiorica, James V.

Obtenir text complet Obtenir text complet Obtenir text complet

Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 Trial per Felix, Ashley S, McMeekin, D Scott, Mutch, David, Walker, Joan L, Creasman, William T, Cohn, David E, Ali, Shamshad, Moore, Richard G, Downs, Levi S, Ioffe, Olga B, Park, Kay J, Sherman, Mark E, Brinton, Louise A

Obtenir text complet Obtenir text complet Obtenir text complet

A Phase II Trial of Brivanib in Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study per Powell, Matthew A., Sill, Michael W., Goodfellow, Paul J., Benbrook, Doris M., Lankes, Heather A., Leslie, Kimberly K., Jeske, Yvette, Mannel, Robert S., Spillman, Monique A, Lee, Paula S., Hoffman, James S., McMeekin, D. Scott, Pollock, Pamela M.

Obtenir text complet Obtenir text complet Obtenir text complet

A Phase II Evaluation of Aflibercept in the Treatment of Recurrent or Persistent Endometrial Cancer: a Gynecologic Oncology Group study per Coleman, Robert L., Sill, Michael W., Lankes, Heather A., Fader, Amanda Nickles, Finkler, Neil J., Hoffman, James S., Rose, Peter G., Sutton, Gregory P., Drescher, Charles W., McMeekin, D. Scott, Hu, Wei, Deavers, Michael, Godwin, Andrew K., Alpaugh, R. Katherine, Sood, Anil K.

Obtenir text complet Obtenir text complet Obtenir text complet

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer per Randall, Marcus E., Filiaci, Virginia, McMeekin, D. Scott, von Gruenigen, Vivian, Huang, Helen, Yashar, Catheryn M., Mannel, Robert S., Kim, Jae-Weon, Salani, Ritu, DiSilvestro, Paul A., Burke, James J., Rutherford, Thomas, Spirtos, Nick M., Terada, Keith, Anderson, Penny R., Brewster, Wendy R., Small, William, Aghajanian, Carol A., Miller, David S.

Obtenir text complet Obtenir text complet Obtenir text complet